Product Information
DOXAZOSIN MESYLATE 2 MG TAB is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.0656 per EA under NDC 59762242007. Its NADAC has been published 231 times since Mar 23, 2022.
FDA first approved this application on Nov 2, 1990. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the doxazosin market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
2 mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
59762242007
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
DOXAZOSIN MESYLATEApproval Type
Authorized Generic (NDA)
FDA Application
NDA019668FDA Approved
11/2/1990
TE Code
AB
On Market Since
10/19/2021
Pharmacological Classes
Price Statistics
The NADAC for DOXAZOSIN MESYLATE 2 MG TAB has been published 231 times since Mar 23, 2022, and over the history we have for it it has declined 22.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0656 per EA |
|---|---|
| All-time high | $0.0864 (Mar 15, 2023) |
| All-time low | $0.0562 (Nov 20, 2024) |
| 52-week high | $0.0716 |
| 52-week low | $0.0656 |
| Median price | $0.0708 |
| Average price | $0.0707 |
| Largest weekly change | +25.5% (Aug 21, 2024) |
| Weeks tracked | 231 |
| Tracking since | Mar 23, 2022 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the doxazosin market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DOXAZOSIN MESYLATE 2 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for DOXAZOSIN MESYLATE 2 MG TAB, manufactured by Mylan Pharmaceuticals Inc., is $0.0656 per EA (NDC 59762242007), effective Aug 19, 2026.
How has the price of DOXAZOSIN MESYLATE 2 MG TAB changed over time?
Over the history we have for it, the NADAC for DOXAZOSIN MESYLATE 2 MG TAB has declined 22.8%. It has been tracked across 231 weekly CMS publications since Mar 23, 2022.
What are the highest and lowest recorded NADAC prices for DOXAZOSIN MESYLATE 2 MG TAB?
Since Mar 23, 2022, the NADAC for DOXAZOSIN MESYLATE 2 MG TAB has ranged from a low of $0.0562 (Nov 20, 2024) to a high of $0.0864 (Mar 15, 2023), with a median of $0.0708 per EA.
Are there cheaper alternatives to DOXAZOSIN MESYLATE 2 MG TAB?
No other NADAC-published product currently shares the active ingredient and strength of DOXAZOSIN MESYLATE 2 MG TAB in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures DOXAZOSIN MESYLATE 2 MG TAB?
DOXAZOSIN MESYLATE 2 MG TAB (NDC 59762242007) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.